NCT05346432 is a NA clinical trial of PS23 in Fatigue, sponsored by Chi-Chang Huang.

Who is sponsoring NCT05346432?

NCT05346432 is sponsored by Chi-Chang Huang.

What drugs are being tested in NCT05346432?

Interventions in NCT05346432: PS23.

Is NCT05346432 still recruiting?

NCT05346432 is currently completed. Last updated 12 July 2022.

Last reviewed 2022-07-12 · How we verify

NCT05346432

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Lactobacillus Paracasei PS23 on Anti-fatigue

Completed NA Last updated 12 July 2022

What this trial tests

NA trial testing PS23 in Fatigue in 120 participants. Completed in 10 July 2022.

Timeline

1 May 2022

Primary endpoint
10 July 2022

10 July 2022

Quick facts

Lead sponsor	Chi-Chang Huang
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	other
Enrollment	120
Start date	1 May 2022
Primary completion	10 July 2022
Estimated completion	10 July 2022
Sites	1 location across Taiwan

Drugs / interventions tested

PS23

Conditions studied

Fatigue — all drugs for Fatigue →

Sponsor

Chi-Chang Huang

Who can join

Adults 20 to 40, any sex, with Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is to explore the effects of supplementing Lactobacillus paracasei PS23 to reduce fatigue and improve physical fitness after exhaustive exercise.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Live and Heat-Killed Probiotic <i>Lactobacillus paracasei</i> PS23 Accelerated the Improvement and Recovery of Strength and Damage Biomarkers after Exercise-Induced Muscle Damage.
Lee MC, Ho CS, Hsu YJ, Huang CC. · · 2022 · cited 29× · PMID 36364825 · DOI 10.3390/nu14214563

Verify or expand the search:

Other recruiting trials for Fatigue

Currently open trials in the same condition.

NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
NCT07421960 — Investigation of the Relationship Between Periodontitis and Sleep Quality · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07386691 — Comparing Effect of Intradialytic Aerobic Exercise Versus Incentive Spirometer on Fatigue and Sleep Quality Among Hemodi · NA · active not recruiting
NCT06819254 — Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors · Phase 4 · recruiting

Other Chi-Chang Huang trials

Trials by the same sponsor.

NCT07168824 — An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition · NA · enrolling by invitation
NCT06486064 — Evaluating the Potential of Probiotic Supplementation Sleep Quality · NA · completed
NCT06062472 — Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly · NA · completed
NCT05412667 — Investigation of TWK10 Administration on the Effects of Amino Acid Absorption · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05346432 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chi-Chang Huang
Last refreshed: 12 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05346432.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing